ClinicalTrials.Veeva

Menu

A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse

Z

Zealand University Hospital

Status

Unknown

Conditions

Vaginal Prolapse

Treatments

Device: Pelvicol

Study type

Interventional

Funder types

Other

Identifiers

NCT00442247
Feb-UH-2007

Details and patient eligibility

About

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced.

Full description

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced. However, is is now known whether these methods are superior to the replication of the pubocervicale fascia, a method which is well described and have been used for many years. Furthermore, most studies evaluating the used of mesh for anterior vaginal wall prolapse have not been controlled studies and been irrespective to whether the repair was a primary or secondary operation.

Sex

Female

Ages

55 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Anterior vaginal wall prolapse greater than grade 2 ICS qualifications, International Continence Society Committee for Standardisation of Terminology

Exclusion criteria

  • Recurrent vaginal prolapse, wault prolapse

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems